Browsing by Author "Penelope Moore"
Now showing 1 - 20 of 26
- Results Per Page
- Sort Options
Item Aberrant innate immune profile associated with COVID19 mortality in Pretoria South Africa(ACADEMIC PRESS INC ELSEVIER SCIENCE) M van der Mescht; Z de Beer; H Steel; R Anderson; Penelope Moore; " "et al"Item Betavariant recombinant booster vaccine elicits broad crossreactive neutralization of SARSCoV2 including Omicron variantsDelphine Planas; Lin Peng; Lingyi Zheng; Florence Guivel-Benhassine; Jinal Bhiman; Penelope Moore; E et alItem Clearance of persistent SARSCoV2 associates with increased neutralizing antibodies in advanced HIV disease postART initiationF Karim; C Riou; M Bernstein; Zesuliwe Jule; Anne Von Gottberg; Penelope Moore; E et alItem Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV a reviewS Mahomed; Kayla Pillay; Razia Hassan-Moosa; Bruna Galvao; Penelope Moore; E et alItem Comparing the immune abnormalities in MISC to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell responseClaire Butters; N Benede; Thandeka Moyo-Gwete; Simone Richardson; Muki Shey; Frances Ayres; Nelia Manamela; Z Makhado; Penelope MooreItem Development of a TwoComponent Nanoparticle Vaccine Displaying an HIV1 Envelope Glycoprotein that Elicits Tier 2 Neutralising AntibodiesKegomoditswe Malebo; Jeremy Woodward; P Ximba; Qiniso Mkhize; Thandeka Moyo-Gwete; Penelope Moore; E et alItem Development of LIBRAseq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV1 vaccinesMatthew Vukovich; N Raju; P Kgagudi; Nelia Manamela; Alexandra Abu-Shmais; Simone Richardson; Penelope Moore; E et alItem Distinct regionspecific neutralization profiles of contemporary HIV1 clade C viruses against best in class broadly neutralizing antibodies(AMER SOC MICROBIOLOGY) Jyoti Sutar; Priyanka Jayal; Ranajoy Mullick; Prajakta Kamble; Dale Kitchin; Haajira Kaldine; Nonhlanhla Mkhize; Penelope Moore; E et alItem Distinct T cell polyfunctional profile in SARSCoV2 seronegative children associated with endemic human coronavirus crossreactivityN Benede; M Tincho; A Walters; V Subbiah; Thandeka Moyo-Gwete; Penelope Moore; E et alItem Evaluating the antibody response elicited by diverse HIV envelope immunogens in the African green monkey Vervet modelThandeka Moyo-Gwete; Frances Ayres; N Mzindle; Z Makhado; Nelia Manamela; Simone Richardson; Dale Kitchin; Strauss van Graan; E et al; Penelope MooreItem Frequency kinetics and determinants of viable SARSCoV2 in bioaerosols from ambulatory COVID19 patients infected with the Beta Delta or Omicron variants(NATURE PUBLISHING GROUP) S Jaumdally; M Tomasicchio; A Pooran; A Esmail; Elizabeth Mayne; Penelope Moore; E et alItem A Global Collaborative Comparison of SARSCoV2 Antigenicity Across 15 LaboratoriesP Brangel; S Tureli; B Mühlemann; N Liechti; Tandile Hermanus; Prudence Diale; Carol Crowther; Simone Richardson; Jinal Bhiman; Penelope Moore; E et alItem Heterologous immunization with improved HIV1 subtype C vaccines elicit Tier 2 neutralizing antibodies with rapid viral replication control after SHIV challengeG Chege; R Chapman; A Keyser; C Adams; Bronwen Lambson; Tandile Hermanus; Penelope Moore; " "et al"Item In utero human cytomegalovirus infection is associated with increased levels of putatively protective maternal antibodies in nonprimary infection evidence for boosting but not protectionJeffrey Dorfman; Sashkia Balla; Jayani Pathirana; Michelle Groome; Shabir Madhi; Penelope MooreItem Isolation and characterization of IgG3 glycantargeting antibodies with exceptional crossreactivity for diverse viral families(PUBLIC LIBRARY SCIENCE) M Vukovich; A Shiakolas; K Lindenbergh; Robert Richardson; Nelia Manamela; Simone Richardson; Penelope Moore; E et alItem Population shift in antibody immunity following the emergence of a SARSCoV2 variant of concernJinal Bhiman; Vimbai Madzorera; Qiniso Mkhize; Cathrine Scheepers; Tandile Hermanus; Frances Ayres; Z Makhado; Thandeka Moyo-Gwete; Carol Crowther; Edmore Marinda; Khangelani Zuma; Lynn Morris; E et al; Penelope MooreItem Protective efficacy of a plantproduced beta variant rSARSCoV2 VLP vaccine in golden Syrian hamstersYolandy Lemmer; R Chapman; Celia Abolnik; Tanya Smith; Tandile Hermanus; Penelope Moore; E et alItem Rare twin cysteine residues in the HIV1 envelope variable region 1 link to neutralization escape and breadth developmentMaria Hesselman; Marius Zeeb; Peter Rusert; Chloe Pasin; Penelope Moore; E et alItem Resistance mutations that distinguish HIV1 envelopes with discordant VRC01 phenotypes from multilineage infections in the HVTN703HPRN081 trial implications for cross resistance(AMER SOC MICROBIOLOGY) Paula Cohen; Bronwen Lambson; Nonhlanhla Mkhize; C Moodley; A Yssel; Thandeka Moyo-Gwete; T York; Asanda Gwashu-Nyangiwe; Lynn Morris; E et al; Penelope MooreItem Safety and immunogenicity of booster vaccination and fractional dosing with Ad26 COV2S or BNT162b2 in Ad26COV2Svaccinated participantsC Riou; Jinal Bhiman; Y Ganga; Shobna Sawry; Frances Ayres; R Baguma; Sashkia Balla; E et al; Nelia Manamela; Faeezah Patel; Thandeka Moyo-Gwete; Simone Richardson; Vera Rees; Penelope Moore; Lee Fairlie